151 related articles for article (PubMed ID: 34047366)
1. Sample size formula for general win ratio analysis.
Mao L; Kim K; Miao X
Biometrics; 2022 Sep; 78(3):1257-1268. PubMed ID: 34047366
[TBL] [Abstract][Full Text] [Related]
2. A win ratio approach to the re-analysis of Multiple Risk Factor Intervention Trial.
Kotalik A; Eaton A; Lian Q; Serrano C; Connett J; Neaton JD
Clin Trials; 2019 Dec; 16(6):626-634. PubMed ID: 31389723
[TBL] [Abstract][Full Text] [Related]
3. Stratified proportional win-fractions regression analysis.
Wang T; Mao L
Stat Med; 2022 Nov; 41(26):5305-5318. PubMed ID: 36104953
[TBL] [Abstract][Full Text] [Related]
4. The stratified win ratio.
Dong G; Qiu J; Wang D; Vandemeulebroecke M
J Biopharm Stat; 2018; 28(4):778-796. PubMed ID: 29172988
[TBL] [Abstract][Full Text] [Related]
5. Power and sample size calculation for the win odds test: application to an ordinal endpoint in COVID-19 trials.
Gasparyan SB; Kowalewski EK; Folkvaljon F; Bengtsson O; Buenconsejo J; Adler J; Koch GG
J Biopharm Stat; 2021 Nov; 31(6):765-787. PubMed ID: 34551682
[TBL] [Abstract][Full Text] [Related]
6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
7. A class of proportional win-fractions regression models for composite outcomes.
Mao L; Wang T
Biometrics; 2021 Dec; 77(4):1265-1275. PubMed ID: 32974905
[TBL] [Abstract][Full Text] [Related]
8. Robust statistical inference for matched win statistics.
Matsouaka RA
Stat Methods Med Res; 2022 Aug; 31(8):1423-1438. PubMed ID: 35578578
[TBL] [Abstract][Full Text] [Related]
9. Calculating power for the Finkelstein and Schoenfeld test statistic for a composite endpoint with two components.
Zhou TJ; LaValley MP; Nelson KP; Cabral HJ; Massaro JM
Stat Med; 2022 Jul; 41(17):3321-3335. PubMed ID: 35486817
[TBL] [Abstract][Full Text] [Related]
10. Power Analysis for Ordinal Analyses of the Modified Rankin Scale and an Online and Downloadable Tool for Practical Use.
Johns H; Campbell B; Turc G; Churilov L
Stroke; 2023 Jul; 54(7):1750-1760. PubMed ID: 37264911
[TBL] [Abstract][Full Text] [Related]
11. Group sequential methods for the Mann-Whitney parameter.
Nowak CP; Mütze T; Konietschke F
Stat Methods Med Res; 2022 Oct; 31(10):2004-2020. PubMed ID: 35698787
[TBL] [Abstract][Full Text] [Related]
12. A sample size formula for the supremum log-rank statistic.
Eng KH; Kosorok MR
Biometrics; 2005 Mar; 61(1):86-91. PubMed ID: 15737081
[TBL] [Abstract][Full Text] [Related]
13. Large sample inference for a win ratio analysis of a composite outcome based on prioritized components.
Bebu I; Lachin JM
Biostatistics; 2016 Jan; 17(1):178-87. PubMed ID: 26353896
[TBL] [Abstract][Full Text] [Related]
14. Win statistics (win ratio, win odds, and net benefit) can complement one another to show the strength of the treatment effect on time-to-event outcomes.
Dong G; Huang B; Verbeeck J; Cui Y; Song J; Gamalo-Siebers M; Wang D; Hoaglin DC; Seifu Y; Mütze T; Kolassa J
Pharm Stat; 2023 Jan; 22(1):20-33. PubMed ID: 35757986
[TBL] [Abstract][Full Text] [Related]
15. On recurrent-event win ratio.
Mao L; Kim K; Li Y
Stat Methods Med Res; 2022 Jun; 31(6):1120-1134. PubMed ID: 35345957
[TBL] [Abstract][Full Text] [Related]
16. Using the geometric average hazard ratio in sample size calculation for time-to-event data with composite endpoints.
Cortés Martínez J; Geskus RB; Kim K; Melis GG
BMC Med Res Methodol; 2021 May; 21(1):99. PubMed ID: 33957892
[TBL] [Abstract][Full Text] [Related]
17. An alternative approach to confidence interval estimation for the win ratio statistic.
Luo X; Tian H; Mohanty S; Tsai WY
Biometrics; 2015 Mar; 71(1):139-145. PubMed ID: 25156540
[TBL] [Abstract][Full Text] [Related]
18. Introducing a new estimator and test for the weighted all-cause hazard ratio.
Ozga AK; Rauch G
BMC Med Res Methodol; 2019 Jun; 19(1):118. PubMed ID: 31185922
[TBL] [Abstract][Full Text] [Related]
19. Sample size under the additive hazards model.
McDaniel LS; Yu M; Chappell R
Clin Trials; 2016 Apr; 13(2):188-98. PubMed ID: 26572562
[TBL] [Abstract][Full Text] [Related]
20. Power and sample size calculation for log-rank test with a time lag in treatment effect.
Zhang D; Quan H
Stat Med; 2009 Feb; 28(5):864-79. PubMed ID: 19152230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
